Single-chain vascular endothelial growth factor variant with antagonist activity
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Single-chain vascular endothelial growth factor variant with antagonist activity. / Boesen, Thomas P; Soni, Bobby; Schwartz, Thue W; Halkier, Torben.
In: Journal of Biological Chemistry, Vol. 277, No. 43, 2002, p. 40335-41.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Single-chain vascular endothelial growth factor variant with antagonist activity
AU - Boesen, Thomas P
AU - Soni, Bobby
AU - Schwartz, Thue W
AU - Halkier, Torben
N1 - Keywords: Amino Acid Sequence; Cells, Cultured; Cloning, Molecular; Dimerization; Electrophoresis, Polyacrylamide Gel; Endothelial Growth Factors; Endothelium, Vascular; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Mitosis; Molecular Sequence Data; Mutagenesis, Site-Directed; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors
PY - 2002
Y1 - 2002
N2 - Vascular endothelial growth factor is a specific endothelial cell mitogen that is essential for the formation of the vascular system but in the adult individual is involved in several pathological conditions, including cancer. It is a homodimeric protein that activates its receptor by binding two receptor molecules and inducing dimerization. By mixing two vascular endothelial growth factor monomers, each with different substitutions, heterodimers with only one active receptor binding site have previously been prepared. These heterodimers bind the receptor molecule but are unable to induce dimerization and activation. However, preparation of heterodimers is cumbersome, involving separate expression of different monomers, refolding the mixture, and separating heterodimers from homodimers. Here we show that a fully functional ligand can efficiently be expressed as a single protein chain containing two monomers. Single-chain vascular endothelial growth factor is functionally equivalent to the wild-type protein. By monomer-specific mutagenesis, one receptor binding site was altered. This variant competitively and specifically antagonizes the mitogenic effect of the wild-type protein on endothelial cells. The results obtained with the single-chain antagonist show the feasibility of the single-chain approach in directing alterations to single specific regions in natural homodimeric proteins that would be impossible to target in other ways.
AB - Vascular endothelial growth factor is a specific endothelial cell mitogen that is essential for the formation of the vascular system but in the adult individual is involved in several pathological conditions, including cancer. It is a homodimeric protein that activates its receptor by binding two receptor molecules and inducing dimerization. By mixing two vascular endothelial growth factor monomers, each with different substitutions, heterodimers with only one active receptor binding site have previously been prepared. These heterodimers bind the receptor molecule but are unable to induce dimerization and activation. However, preparation of heterodimers is cumbersome, involving separate expression of different monomers, refolding the mixture, and separating heterodimers from homodimers. Here we show that a fully functional ligand can efficiently be expressed as a single protein chain containing two monomers. Single-chain vascular endothelial growth factor is functionally equivalent to the wild-type protein. By monomer-specific mutagenesis, one receptor binding site was altered. This variant competitively and specifically antagonizes the mitogenic effect of the wild-type protein on endothelial cells. The results obtained with the single-chain antagonist show the feasibility of the single-chain approach in directing alterations to single specific regions in natural homodimeric proteins that would be impossible to target in other ways.
U2 - 10.1074/jbc.M204107200
DO - 10.1074/jbc.M204107200
M3 - Journal article
C2 - 12151391
VL - 277
SP - 40335
EP - 40341
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
SN - 0021-9258
IS - 43
ER -
ID: 162972